TRHC TABULA RASA HEALTHCARE

TRHC and ASCP Sign Letter of Intent to offer MedWiseâ„¢ to Consultant Pharmacists

TRHC and ASCP Sign Letter of Intent to offer MedWise™ to Consultant Pharmacists

Goal: Improve medication safety

MOORESTOWN, N.J., May 11, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare®, Inc. (TRHC) (Nasdaq: TRHC), a healthcare technology company advancing the field of medication safety, today announces it has signed a Letter of Intent with a membership association that represents pharmacists, healthcare professionals and students serving the unique medication needs of older adults. The first of its kind, the strategic collaboration will jointly offer TRHC’s medication safety software, to the pharmacist membership of ASCP. 

The principal value proposition of the collaboration is a working partnership between TRHC and ASCP to improve medication safety in patients who have a high burden of disease and complex medication regimens, while also developing consultant pharmacist workflow recommendations for its use.

According to ASCP’s Chief Executive Chad Worz, PharmD, BCGP, “Innovative tools, like MedWise, can increase the value of ASCP’s consultant pharmacists’ work to improve medication safety for senior care patients and residents of long-term care facilities by providing critical insight into the medications being prescribed and consumed.” 

TRHC’s MedWise is a proprietary medication-safety technology that helps pharmacists manage and optimize regimens by presenting meaningful opportunities to mitigate risks. Benefits include simultaneous multi-drug analysis; identifying, resolving, and preventing adverse drug events; and reducing hospitalizations and emergency visits. 

“For every dollar spent on prescription medication in this country, we spend more than another dollar trying to address medication-related problems,” said THRC Chairman and CEO Calvin H. Knowlton, PhD. “We believe this collaboration with ASCP, which also provides pharmacists the opportunity to become certified MedWise Advisor™ pharmacists, will improve medication safety, prevent adverse drug events, and reduce total cost of care, while also strengthening and building relationships with patients and healthcare teams.” 

About Tabula Rasa HealthCare

Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize performance to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations. For more information, visit

ASCP: Empowering Pharmacists. Transforming Aging.

ASCP is a membership association that represents pharmacists, health care professionals, and students serving the unique medication needs of older adults. ASCP is an international organization with members located in all 50 states, Puerto Rico, and 12 countries. The society’s mission is to promote healthy aging by empowering pharmacists with education, resources, and innovative opportunities. Learn more at .

Forward-Looking Statements

This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology.  Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions.  These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release.  Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC,  including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 2, 2020, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.

Media Contact

Dianne Semingson



T: (215) 870-0829
Investors

Frank Sparacino



T: (312) 451-2157

Amanda Bednar                                                                     



T: (856) 912-5714

Christine Polite

EN
11/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on TABULA RASA HEALTHCARE

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: July 27, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: July 25, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Tabula Rasa Healthcare Inc: 3 directors

A director at Tabula Rasa Healthcare Inc bought 2,000 shares at 5.630USD and the significance rating of the trade was 34/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch